After adjustment for time-variant confounding factors, pneumonia was not associated with use of ACE inhibitors or ARBs; the ORs (95% CI) were 0.99 (0.81–1.21) and 0.96 (0.72–1.28), respectively. This evidence concerns the gene ACE and susceptibility to pneumonia measurement.